Design of Synthetic Peptidic Constructs for the Vaccine Development Against Viral Infections

Publisher： Bentham Science Publishers

E-ISSN： 1875-5550|5|6|425-433

ISSN： 1389-2037

Source： Current Protein and Peptide Science, Vol.5, Iss.6, 2004-12, pp. : 425-433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of a Mimotope-Based Vaccine Against CD20 Antigen

By  

Protein and Peptide Letters, Vol. 14, Iss. 6, 2007-06 ,pp. : 610-614

Bentham Science Publishers

Access to resources Recommend Favorite

Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design

By Chen Weizao   Ying Tianlei   Dimitrov Dimiter S  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-06 ,pp. : 657-671

Informa Healthcare

Access to resources Recommend Favorite

Binding of High-Mannose-Type Oligosaccharides and Synthetic Oligomannose Clusters to Human Antibody 2G12 - Implications for HIV-1 Vaccine Design

By Wang L.-X.   Ni J.   Singh S.   Li H.  

Chemistry & Biology, Vol. 11, Iss. 1, 2004-01 ,pp. : 127-134

Elsevier

Access to resources Recommend Favorite

The development of potent non-peptidic PTP-1B inhibitors

By Dufresne C.   Roy P.   Wang Z.   Asante-Appiah E.   Cromlish W.   Boie Y.   Forghani F.   Desmarais S.   Wang Q.   Skorey K.   Waddleton D.   Ramachandran C.   Kennedy B.P.   Xu L.   Gordon R.   Chan C.C.   Leblanc Y.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 4, 2004-02 ,pp. : 1039-1042

Elsevier

Access to resources Recommend Favorite

Emerging viral infections in a rapidly changing world

By Kuiken T.   Fouchier R.   Rimmelzwaan G.   Osterhaus A.  

Current Opinion in Biotechnology, Vol. 14, Iss. 6, 2003-12 ,pp. : 641-646

Elsevier

Access to resources Recommend Favorite